Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Net Income 2010–2025
Supernus Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2010 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Supernus Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -2.3 M, a 80.61% decrease year-over-year.
- Supernus Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -36.7 M, a 186.32% decrease year-over-year.
- Supernus Pharmaceuticals Inc. annual net income for 2025 was -38.5 M, a 152.19% decrease from 2024.
- Supernus Pharmaceuticals Inc. annual net income for 2024 was 73.9 M, a 5512.84% increase from 2023.
- Supernus Pharmaceuticals Inc. annual net income for 2023 was 1.3 M, a 97.83% decrease from 2022.
- Supernus Pharmaceuticals Inc. annual net income for 2022 was 60.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Supernus Pharmaceuticals Inc. Net Income — FAQ
Supernus Pharmaceuticals Inc. (SUPN) net income over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Supernus Pharmaceuticals Inc.'s net income?
Supernus Pharmaceuticals Inc. (SUPN) reported net income of -$39M for fiscal 2025.
Where can I see SUPN's net income history?
The chart and table above show Supernus Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.